baber/WOPTO huggingface dataset:
Patent JP-2000506186-A (JP)
Title: 芳香族無水物硬化剤を用いるエポキシ化ジエンポリマーの改良された化学的硬化
IPC: C09K3/10
Filed: 1997-02-13
Abstract: (57)【要約】
本発明は、接着剤、シーラントおよびコーティング剤で使用するエポキシ化ジエンポリマーの硬化方法において、該ポリマーと、ポリマー／芳香族無水物のモル比０．５／１〜２．０／１．０での芳香族無水物硬化剤および適宜に０．１〜１０ｐｈｒの促進剤とを、１００〜２００℃の温度で、１０分間〜６時間接触させる段階を有してなる方法に関するものである。本発明はさらに、架橋エポキシ化ポリジエンポリマーならびに接着剤、シーラントまたはコーティング剤組成物に関するものである。
Patent JP-2001511767-A (JP)
IPC: A61K31/395
Filed: 1997-12-19
Abstract: The instant invention is concerned with aryl and heteroaryl oxyacetic acid type compound which are useful antidiabetic compounds. Compositions and methods for the use of the compounds in the treatment of diabetes and related diseases and for lowering triglyceride levels are also disclosed.
Patent JP-H10500451-A (JP)
IPC: C23C16/52
Filed: 1995-04-01
Abstract: PCT No. PCT/DE95/00449 Sec. 371 Date Sep. 27, 1996 Sec. 102(e) Date Sep. 27, 1996 PCT Filed Apr. 1, 1995 PCT Pub. No. WO95/32317 PCT Pub. Date Nov. 30, 1995A tool is made in a coating vessel, depositing upon the base tool body of a hard metal or cermet, a coating by chemical vapor deposition by admitting to the vessel a reactive gas mixture capable of forming a composition selected from the group which consists of aluminum oxide and of titanium and zirconium carbide, nitride and carbonitride, and of mixtures thereof at a chemical vapor deposition pressure and temperature; and interrupting the chemical vapor deposition by a multiplicity of times by replacing the reactive gas mixture with a nonreactive gas mixture containing components selected from the group which consists of argon, hydrogen, nitrogen and mixtures thereof, lowering a pressure in the vessel to a plasma chemical vapor deposition pressure of 10 to 1000 Pa, effecting a glow discharge at the body with the body being cathodically connected at a negative D.C. voltage of 200 to 1000 volts for a period of 1 to 30 minutes, to effect plasma chemical vapor deposition coating between chemical vapor deposition coating with the reactive mixture.
Patent JP-2000505211-A (JP)
Title: テクスチャードガラス表面を有する耐結露性再帰反射交通標識
IPC: E01F9/619
Filed: 1997-01-16
Abstract: (57)【要約】
ガラス板を前面に配設してなる耐結露性再帰反射交通標識。ガラス板は、空気に曝露されるテクスチャード表面を有する。テクスチャード表面は、標識に耐結露性を付与する。耐結露性交通標識の製造方法についても記載する。
Patent JP-2001511151-A (JP)
Title: 表皮又は皮膚疾患部の処理方法と形質転換動物
IPC: A61K8/00
Filed: 1998-02-03
Abstract: (57)【要約】
皮膚の酸化窒素（ＮＯ）の量を調整する処置剤を被処置動物に投与することによりなる、不所望の表皮又は皮膚疾患を処置する方法。
Patent JP-2001513719-A (JP)
Title: ポリアミドブロックと親水性ブロックとを有するコポリマーで被覆された基材を有する多層構造物
IPC: C08G69/44
Filed: 1998-12-23
Abstract: (57)【要約】
コポリマーは１３５℃以下、好ましくは９０℃〜１３５℃の融点を有するポリアミドブロックと親水性ブロックとを有するコポリマーで被覆された基材から成る多層構造物。本発明構造物は液体の水は遮断し、水蒸気は通す。本発明は上記ポリアミドブロックと親水性ブロックとを有するコポリマーの製造方法と、ポリアミドブロックとポリエーテルブロックとを有する新規コポリマーとに関するものである。
Patent JP-2001515564-A (JP)
Title: 内燃エンジンの燃料噴射装置に燃料圧力チューブを連結する装置および方法
IPC: F02M61/14
Filed: 1998-12-23
Abstract: (57)【要約】
内燃エンジン用の側面供給燃料噴射装置２に燃料圧力チューブ９を連結し、燃料噴射装置２から燃料供給システムのための取出し位置へリークバック送りするための導管を形成する装置が記載される。この装置は、噴射装置本体に取付けられるように且つ燃料圧力チューブ９を受止めるように作用するホルダー手段と、ホルダー手段１０と協働してリークバック受容器３４を形成するように形状を形成されたハウジング部材８と、噴射装置からのリークバック流れを導くことができ、且つ再使用のためにリークバック燃料の制御された送出を可能にするダクトとを含んで成る。このような装置の使用方法も記載される。
Patent JP-H11511242-A (JP)
Title: 湿潤ガスの露点測定の方法と装置
IPC: G01N25/68
Filed: 1996-05-31
Abstract: (57)【要約】
湿潤ガス（Ａ）の流れが表面（２）の上を通過し、湿気センサ（５）が表面（２）より下流のガスの流れの中に位置取りされ、冷却が表面に供給され、表面（２）より下流のガスの湿気含有量（Ｍ）が監視され、露点温度（Ｔ D ）での湿潤ガスからの湿気の凝縮による湿気含有量の低下の検出によって制御されながら測定する表面（２）の温度が測定されることを包含する湿潤ガスの露点温度の測定方法である。本方法を実行するための装置も、又、記述される。表面（２）はヒート  ポンプ（３）に接触する熱伝導性物質の層であり得るし、あるいは、コイル状のチューブ（40）の壁の部分であり得る。
Patent JP-2000508534-A (JP)
Title: 液体供給装置
IPC: A01M21/04
Filed: 1997-04-18
Abstract: (57)【要約】
液体散布装置（５０）は、散布されるべき液体用貯槽を形成する円形断面の管（５２）の細長い本体を備える。ハンドル（５６）は、この管の一端部に設けられ、弁がこの管の他端部に設けられている。弁（５４）は弁側端部を地面に押すことにより開弁する。計量手段が弁（５４）の作動時に１回分の液体を散布できるように設けられている。好ましい実施例では、散布される液体は除草剤である。
Patent JP-2001513957-A (JP)
Title: 複合キャリア信号の分析方法および装置
IPC: H04J1/02
Filed: 1998-01-20
Abstract: (57)【要約】
通信システムは、コーディング指定にしたがって、複数の情報信号を受信しコード化して、複数のコード化ベースバンド信号を生成する。これらの信号から、複数のコード化ベースバンド信号を形成した場合に得られる実際の複合キャリア信号の特性を全て有する、シミュレート複合キャリア信号を形成する。このシミュレート複合キャリア信号を分析し、そのピーク対平均比率を決定する。通信システムは、決定したピーク対平均比率および選択基準に基づいて、コーディング指定が所望の結果を生成しない場合、異なるコーディング指定を選択し、複数の情報信号をコード化する。通信システムは、少なくとも１つまたは数個の所望のコーディング技法が識別されるまで、異なるコーディング指定を選択し、これらのコーディング技法を格付けし、ピーク対平均比率の要件を満たすコーディング技法の最終的選択を行う。
Patent JP-2000509503-A (JP)
Title: 浮揚汚染物質の検出
IPC: G01N21/53
Filed: 1997-05-02
Abstract: (57)【要約】
散乱光の原理により動作する煙検出器（２）は、光線（１０）が通過する検出チャンバ（４）を備える。連続的に寸法が大きくなる開口を備える直列に配置されたコリメートディスク（２４，２６，２８）は、煙粒子の存在により誘発される散光の存在の検出が行われるチャンバの領域に光線のグリントが入射するのを防止する。検出チャンバの光源と離れた端部にある光吸収器（１２）は、光線が向けられる非対称円錐形状のターゲット面（４２）を備える。コリメートディスク及び光吸収器の設計により迷光が出現が防止され、感度が向上する。
Patent JP-2001519999-A (JP)
Title: 同期整流による切換電圧変換器
IPC: H02M3/335
Filed: 1999-01-25
Abstract: (57)【要約】
ダイオード（１６）及び並列接続された電子スイッチ（１８）によった同期整流による切換電源である。単発回路（ＯＳ）によって電子スイッチ（１８）が、ダイオード（１６）が電子スイッチ（１８）無しで導通であり得る時間期間のうちの一定の部分の間導通に駆動される。
Patent JP-2000510906-A (JP)
Title: 着色メタリック塗装を有する物品及びそれらを製造する方法
IPC: C23C28/02
Filed: 1997-05-15
Abstract: (57)【要約】
ある物品が金属又はプラスチック素地（２）上に支持されている銅、真鍮、光沢ニッケル又はつや消しニッケルの下地（４）上に、ニッケル及び亜鉛の両方を含む着色電気めっきメタリック塗装（６）を含んでいる。電気めっき塗装の色の変動は、電解質中のカチオン（Ｎｉ 2+ 、Ｚｎ 2+ 、（ＮＨ 4 ） + 及びチオシアン酸塩アニオン）の同一性には依存しておらず、カソードの下地での電流密度が０．０１〜０．５Ａ／ｄｍ 2 の範囲内にあることを条件に、むしろ排他的に電流密度、電気めっき工程の時間及び電流量に依存している。
Patent JP-2001523266-A (JP)
Title: エストロゲンとして活性な３−ヒドロキシ−エストラ−５（１０）−エン−１７−オンの３−硫酸エステルの医薬上許容される塩
IPC: A61P43/00
Filed: 1998-04-28
Abstract: (57)【要約】
本発明は、エストロゲンとして有用な３β-ヒドロキシ-５(１０)-エストレン-１７-オンの３-硫酸エステルの医薬上許容される塩および３α-ヒドロキシ-５(１０)-エストレン-１７-オンの３-硫酸エステルの医薬上許容される塩を提供する。
Patent JP-2001525809-A (JP)
Title: プロテアーゼ阻害剤
IPC: A61K31/4709
Filed: 1998-05-06
Abstract: (57)【要約】
本発明は、式（Ｉ）：
 ［式中、ＹはＡｒまたはＮＲ 1 Ｒ 2 であり；Ｒ 1 はＲ''、Ｒ''Ｃ(Ｏ)、Ｒ''Ｃ(Ｓ)、Ｒ''ＳＯ 2 、Ｒ''ＯＣ(Ｏ)、Ｒ''Ｒ'ＮＣ(Ｏ)、またはＲ''Ｒ'ＮＣ(Ｓ)であり；Ｒ 2 はＨ、Ｃ 1-6 アルキル、Ｃ 2-6 アルケニル、Ａｒ−Ｃ 0-6 アルキル、またはＨｅｔ−Ｃ 0-6 アルキルであり；Ｒ 3 はＨ、Ｃ 2-6 アルケニル、Ｃ 2-6 アルキニル、Ｈｅｔ、Ａｒであるか、またはＯＲ'、ＳＲ'、ＮＲ' 2 、Ｎ(Ｒ')Ｃ(Ｏ)ＯＲ''、ＣＯ 2 Ｒ'、ＣＯ 2 ＮＲ' 2 、Ｎ(Ｃ＝ＮＨ)ＮＨ 2 、ＨｅｔもしくはＡｒにより置換されていてもよいＣ 1-6 アルキルであり；Ｒ 4 はＨ、Ｃ 1-6 アルキル、Ｃ 2-6 アルケニル、Ａｒ−Ｃ 0-6 アルキル、またはＨｅｔ−Ｃ 0-6 アルキルであり;Ｒ 5 は式(ａ)
 Ａｒ−Ｃ 0-6 アルキル、Ｈｅｔ−Ｃ 0-6 アルキル、アダマンチル−Ｃ(Ｏ)−、Ａｒ−Ｃ(Ｏ)−、またはＨｅｔ−Ｃ(Ｏ)−であり；Ｒ 6 はＲ''、Ｒ''Ｃ(Ｏ)、Ｒ''Ｃ(Ｓ)、Ｒ''ＳＯ 2 、Ｒ''ＯＣ(Ｏ)、Ｒ''Ｒ'ＮＣ(Ｏ)、Ｒ''Ｒ'ＮＣ(Ｓ)、またはＲ''ＯＣ(Ｏ)ＮＲ'ＣＨ(Ｒ * )Ｃ(Ｏ)であり；Ｒ 7 はＣ 3-6 シクロアルキル−Ｃ 0-6 アルキル、Ａｒ−Ｃ 0-6 アルキル、Ｈｅｔ−Ｃ 0-6 アルキル、Ａｒ−Ｃ 0-6 アルコキシ、Ｈｅｔ−Ｃ 0-6 アルコキシであるか、またはＯＲ'、ＳＲ'、ＮＲ' 2 、Ｎ(Ｒ')Ｃ(Ｏ)ＯＲ''、ＣＯ 2 Ｒ'、ＣＯ 2 ＮＲ' 2 、Ｎ(Ｃ＝ＮＨ)ＮＨ 2 、ＨｅｔもしくはＡｒにより置換されていてもよいＣ 1-6 アルキルであり；Ｒ * はＨ、Ｃ 1-6 アルキル、Ｃ 2-6 アルケニル、Ｃ 3-6 シクロアルキル−Ｃ 0-6 −アルキル、Ａｒ−Ｃ 0-6 アルキル、Ｈｅｔ−Ｃ 0-6 アルキルであり；各Ｒ'は独立してＨ、Ｃ 1-6 アルキル、Ｃ 2-6 アルケニル、Ａｒ−Ｃ 0-6 アルキル、またはＨｅｔ−Ｃ 0-6 アルキルであり；各Ｒ''は独立してＣ 1-6 アルキル、Ｃ 3-6 シクロアルキル−Ｃ 0-6 −アルキル、Ａｒ−Ｃ 0-6 アルキル、またはＨｅｔ−Ｃ 0-6 アルキルであり；Ｒ'''はＨ、Ｃ 1-6 アルキル、Ｃ 3-6 シクロアルキル−Ｃ 0-6 アルキル、Ａｒ−Ｃ 0-6 アルキル、またはＨｅｔ−Ｃ 0-6 アルキルであり；ＺはＣ(Ｏ)またはＣＨ 2 であり；ｎは１、２または３である］で示される化合物またはその医薬上許容される塩に関し、それらはシステインプロテアーゼ、特にカテプシンＫの阻害剤であり、骨の損失の抑制が因子となっている疾病の治療に有用である。
Patent MD-20060080-A (MD)
Inventor: VISCOMI GIUSEPPE C
IPC: A61P31/04
Filed: 2004-11-04
Abstract: Inventia se refera la formele polimorfe cristaline de rifaximin alpha si rifaximin beta, precum si la forma subcristalina de rifaximin y folosite la fabricarea medicamentelor cu continut de rifaximin pentru administrare orala si locala, obtinute prin cristalizare, care se realizeaza prin diluarea rifaximinului brut in alcool etilic fierbinte. Cristalizarea produsului este initiata prin adaugareaapei la o temperatura anumita, pe parcursul unui anumit interval de timp, dupa care se realizeaza uscarea sub control, pana cand produsul finit ajunge la un anumit continut de apa.
Patent MX-157800-A (MX)
Inventor: HAHN EDWARD H
IPC: D21F1/00
Filed: 1981-08-27
Abstract: A papermaking fabric of the multilayer type having threads of a multiple layer thread system extending in one fabric direction and threads of a single layer thread system extending in the other fabric direction which are interwoven with the threads of each of the multiple layers. The threads of the single layer thread system are spaced apart from one another, and threads of the several layers are tiered above one another with spacing between tiers, so that the fabric has a significant projected open area that allows spray water to penetrate the fabric. The fabric may also have an increased void volume in its interior and binding points between thread systems that are well spaced from one another to enhance the papermaking qualities of the fabric.
Patent MX-161222-A (MX)
Inventor: BRENNER HEINZ
IPC: F16F1/38
Filed: 1985-05-23
Abstract: The invention provides an elastic articulated coupling which comprises a relatively rigid inner member having a longitudinal axis, a relatively rigid outer member having a generally cylindrical interior of a predetermined first diameter surrounding said inner member with substantial clearance, and an elastomeric body located in the clearance between the inner and outer members. The elastomeric body is connected firmly to the inner member. Additionally, a sleeve comprising wear-resistant elastic material is firmly connected to the elastomeric body and disposed between the elastomeric body and the outer member. The elastomeric body and the sleeve together have a predetermined second diameter which is greater than the predetermined first diameter defined by the interior of the generally cylindrical outer member. As a result, the sleeve is connected in a non-positive manner with the interior surface of the outer member merely by radial pre-stressing and by axial bracing.
Patent NZ-207993-A (NZ)
Title: Lift-type check valve for use as diffuser valve in hopper
Inventor: HUTT J J
IPC: B65D88/72
Filed: 1984-04-30
Abstract: A diffuser valve adapted to be fixed in the wall (9) of a storage hopper containing particulate materials and operable to dispense an air blast into the interiors of the hopper to loosen material in the region of the valve. The valve has a tubular body (1) accommodating a valve member (2) which opens to dispense the air blast in a radial direction along the walls (9) of the hopper to which it is fixed.
Patent NZ-218200-A (NZ)
Title: Expandable honeycomb structure for use as collapsible blinds
Inventor: ANDERSON R N
IPC: B31D3/02
Filed: 1986-11-06
Abstract: An expandible honeycomb structure such as used for window coverings made of a foldable material which, in the expanding condition, defines a plurality of longitudinal extending cells (l4), one on top of the other. The material of each cell is adhered to the adjacent cell along at least one portion (28) in which the material is less permeable than the remainder of the material forming the cell to prevent seeping or bleeding of the adhesive.
Patent NZ-218643-A (NZ)
Title: Regenerating spent hydrocarbon conversion catalysts
Inventor: GREENWOOD A R
IPC: B01J38/24
Filed: 1986-12-16
Abstract: Regeneration of a spent hydrocarbon conversion catalyst is accomplished by means of a moving bed of catalyst, where catalyst is passed through several treatment zones, in a unique regeneration vessel. The catalyst is first contacted with a hot oxygen-containing gas stream in a burning zone in order to remove coke. The catalyst is then passed into a drying zone for removal of water formed in the combustion zone by passing a hot dry air stream through the catalyst. This hot air stream is produced by exchange of heat with catalyst, thereby effecting cooling of the regenerated catalyst and by use of an air heating means located in the vessel. After passing through the drying zone, the air stream provides oxygen for combustion in the combustion zone.
Patent NZ-222949-A (NZ)
Title: Use of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h- carbazol-4-one for the manufacture of medicaments
Inventor: TYERS MICHAEL BRIAN
IPC: A61K31/415
Filed: 1987-12-16
Abstract: The invention relates to the use of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H</ U>-carbazol-4-one and physiologically acceptable salts and solvates thereof in the treatment of depression.
Patent NZ-224808-A (NZ)
Title: Recombinant dna sequences coding for human proapolipoprotein a-i
Inventor: BOLLEN A
IPC: C12N15/12
Filed: 1988-05-26
Abstract: The present invention provides recombinant DNA sequences comprising a sequence which codes for human proapolipoprotein A-I wherein part of the natural coding sequence has been replaced by a DNA fragment coding for the same amino acids but consisting of a different nucleotide sequence such as to reduce or prevent formation of hairpins, cloning and expression vectors containing these DNA sequences, cell cultures or microorganisms transformed with these expression vectors and processes using the same for the production of proapolipoprotein A-I.
Patent NZ-238812-A (NZ)
Title: Protein comprising enzyme-like binding protein and variable fused polypeptide coupled by interconnecting peptide
Inventor: COOLIDGE THOMAS R
IPC: C07K19/00
Filed: 1991-07-01
Abstract: The present invention is directed to a protein purification construct having three tandem, coupled segments composed of a binding protein, an interconnecting linker and a variable fused polypeptide which incorporates the one or more copies of a product peptide. The binding protein is a mammalian or human carbonic anhydrase, or a modified version of the carbonic anhydrase. The protein purification construct may be employed in methods for expression of the product peptide in microbial and higher organism and for ligand immobilized affinity purification of the product peptide.
Patent NZ-248571-A (NZ)
Title: Synergistic herbicide comprising isoproturon and flurtamone
Inventor: ROGNON JACQUES
IPC: A01N37/00
Filed: 1993-09-02
Abstract: The present invention provides a method of controlling the growth of weeds using (a) flurtamone and (b) isoproturon; and herbicidal compositions comprising (a) and (b) are described.
Patent NZ-249588-A (NZ)
Title: Anthelmintic agent
Inventor: NISHIYAMA HITOSHI
IPC: A61K39/395
Filed: 1993-03-08
Abstract: A compound represented by general formula (I) or a salt thereof, excellent in parasiticidal activity as an enthelmintic for animal and man, wherein A represents benzyl which is appropriately substituted or phenyl which may be appropriately substituted; A<a> represents benzyl or phenyl each of which may be appropriately substituted; B and D represent each lower alkyl; and C represents hydrogen or lower alkyl. <CHEM>
Patent NZ-269571-A (NZ)
Title: N-phenyl-2-thiophenecarboximidimide, -benzenecarboximidimide, various heterocyclic carboximidimide and -perfluoroalkanecarboximidimide derivatives
Inventor: GENTILE ROBERT JAMES
IPC: A61P25/00
Filed: 1994-08-12
Abstract: The present invention relates to methods and compositions useful for treating and preventing conditions in which inhibition of nitric oxide synthetase is beneficial. These conditions include stroke, schizophrenia, anxiety, and pain.
Patent NZ-277034-A (NZ)
Title: Controlled release composition, actives in matrix covered with variable thickness erodible solid material
Inventor: CREMER KARSTEN
IPC: A61K9/20
Filed: 1994-11-23
Abstract: A device for the controlled release of active substances in liquid media from an active substance-containing matrix exhibiting active substance releasing-surfaces has, the active substance releasing surfaces of the matrix covered, at least partially, by an erodible mass of solids; the thickness of the erodible mass across its extent on the active substance releasing-areas is determined by gradients.
Patent NZ-292263-A (NZ)
Title: Sustained release preparations comprising a polyvalent metal salt of water-soluble peptide and a biodegradable polymer
Inventor: IGARI YASUTAKA
IPC: A61K38/27
Filed: 1995-09-06
Abstract: A sustained-release preparation containing a water-insoluble or slightly water-soluble polyvalent metal salt of a water-soluble peptide type of physiologically active substance except for an endothelin antagonist and a biodegradable polymer. The present invention is a sustained-release preparation that is highly efficient in incorporating a water-soluble peptide type of physiologically active substance except for an endothelin antagonist and suppresses initial burst of the water-soluble peptide type of physiologically active substance except for an endothelin antagonist. The sustained-release preparation of the present invention is capable of releasing the water-soluble peptide type of physiologically active substance except for an endothelin antagonist while retaining its bioactivity after administration in vivo. Furthermore, the water-soluble peptide type of physiologically active substance except for an endothelin antagonist in the sustained-release preparation is kept stable for a long period of time, with little loss of bioactivity.
Patent NZ-294176-A (NZ)
Title: Medicaments containing tamoxifen derivatives and analogues and a naphthyl derivative; a method of minimizing the uterotrophic effect of tamoxifen and its analogues
Inventor: BRYANT HENRY UHLMAN
IPC: A61K31/135
Filed: 1995-09-18
Abstract: The present invention provides a method of minimizing the uterotrophic effect of non-steroidal antiestrogen compounds of formula II <CHEM>  wherein either R<4> is H or a lower alkyl radical and R<5> is a lower alkyl radical, or R<4> and R<5> are joined together with the adjacent nitrogen atom to form a heterocyclic radical;     R<6> is H or a lower alkyl radical; R<7> is H, halo, OH, a lower alkyl radical, or is a buta-1,3-dienyl radical which together with the adjacent benzene ring forms a naphthyl radical;     R<8> is H or OH; and     n is 2; or a pharmaceutically acceptable salt thereof, wherein said formula II compound is administered to a woman for the treatment or prevention of breast carcinoma, comprising concurrently or sequentially administering to said woman a compound of formula I <CHEM>  wherein R<1> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R<2> is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl);     n is 2 or 3; and R<3> is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino;  or a pharmaceutically acceptable salt thereof. The present invention further provides pharmaceutical compositions comprising a compound of formula I and a compound of formula II together with a pharmaceutically acceptable carrier, excipient, or diluent.
Patent NZ-297797-A (NZ)
Title: Benzenesulphonamide derivatives
Inventor: BREU VOLKER
IPC: A61K31/506
Filed: 1995-12-08
Abstract: PCT No. PCT/EP95/04843 Sec. 371 Date Aug. 15, 1997 Sec. 102(e) Date Aug. 15, 1997 PCT Filed Dec. 8, 1995 PCT Pub. No. WO96/19459 PCT Pub. Date Jun. 27, 1996Compounds of the formula: where A, B, R1-R8 are as described herein are endothelin inhibitors that can be used in treating diseases associated with endothelin, such as high blood pressure. Chemical synthesis of these compounds and pharmaceutical compositions containing these compounds are also useful.
Patent NZ-300493-A (NZ)
Title: Fabric softener compositions that are clear, aqueous microemulsion compositions comprising organic solvents and diester or diamido quaternary ammonium compounds
Inventor: GRANDMAIRE JEAN-PAUL
IPC: C11D3/43
Filed: 1995-12-19
Abstract: Clear fabric softener microemulsion compositions have been developed for use in the rinse cycle comprising a combination of diester quaternary ammonium surfactants, diamido ammonium surfactants and selected organic solvents. Fatty co-softeners and oil perfumes may be included as optional ingredients. These microemulsions are converted to macroemulsions upon dilution with water in the rinse cycle to provide a fabric softening treatment.
Patent NZ-330822-A (NZ)
Title: Reactive coupling of sensor and control signals onto powerline transmission media
Inventor: WIESMAN RICHARD M
IPC: G01R15/18
Filed: 1997-10-30
Abstract: A non-invasive powerline communications system includes: means for generating communication signals at a first location for transmission on a powerline; means for reactively coupling the communication signals to the powerline; and means for receiving said communication signals at a second location
Patent NZ-331615-A (NZ)
Title: Components comprising a polymeric material blended with carbon black for inhalation devices
Inventor: WIDERSTROM CARIN
IPC: A61M15/00
Filed: 1997-03-20
Abstract: A component for use in an inhalation apparatus is described.  The component is made of or is coated with a polymeric material loaded with carbon black in an amount sufficient to impart to the polymeric material a specific volume resistivity of less than 109 Ohmcm.
Patent NZ-336529-A (NZ)
Title: 3-Aryl substituted pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical use
Inventor: YUAN JUN
IPC: A61P25/24
Filed: 1997-12-23
Abstract: Compounds of the formula depicted above selectively bind to corticotropin-releasing factor (CRF1) receptors and may be useful in the diagnosis and treatment of treating stress related disorders such as post-traumatic stress disorder (PTSD) as well as depression, headache and anxiety. n the formula above; Ar is phenyl, 1- or 2-naphthyl, 2-, 3-, or 4-pyridinyl, 2- or 3-thienyl, 4- or 5-pyrimidinyl, each of which is mono-, di-, or trisubstituted with halogen, hydroxy, lower alkyl, or lower alkoxy, provided that at least one of the positions on Ar, ortho to the point of attachment to the pyrazole ring, is substituted; R1 is lower alkyl; R2 is hydrogen, halogen, lower alkyl, lower alkoxy, or thioalkoxy having 1-6 carbon atoms; and R3 and R4 are the same or different and represent hydrogen, lower alkyl, alkoxy lower alkyl, hydroxy lower alkyl, or alkenyl; phenyl, 2-, 3-, or 4-pyridinyl, 2- or 3-thienyl or 2-, 4- or 5-pyrimidinyl, each of which is optionally mono- or disubstituted with halogen, hydroxy, lower alkyl, or lower alkoxy; phenyl-, 2-, 3-, or 4-pyridinyl-, 2- or 3-thienyl-, or 2-, 4- or 5-pyrimidinyl-lower alkyl, each of which is optionally mono- or disubstituted with lower alkyl; cycloalkyl or cycloalkyl lower alkyl, each of which is optionally mono- or disubstituted with lower alkyl; or 2-hydroxyethyl or 3-hydroxypropyl, each of which is optionally monosubstituted with lower alkyl: provided that not both R3 and R4 are hydrogen; or R3 and R4 taken together represent -(CH2)n-A-(CH2)m where; n is 2 or 3; A is methylene, 1,2-phenylene, oxygen, sulfur or NR6, wherein R6 is lower alkyl, phenyl, 2-, 3-, or 4-pyridinyl, 2-or 3-thienyl or 2-, 4- or 5-pyrimidinyl, or phenyl, 2-, 3-or 4-pyridinyl-, 2-or 3-thienyl-, or 2-, 4- or 5-pyrimidinylalkyl; and m is 1, 2 or 3.
Patent NZ-500569-A (NZ)
Title: A method and culture of Bacillus subtilis (NRRL-B-21974) for inhibiting undesired microorganisms
Inventor: RAY PURBITA
IPC: A23L3/3571
Filed: 1998-04-22
Abstract: Provided is Bacillus subtilis (NRRL -B-21974) and a method of inhibiting undesirable microorganisms in a material, such as food or feed and packaging material for food or feed, by exposing the material to a culture of Bacillus subtilis or a concentrate thereof.
Patent NZ-503821-A (NZ)
Title: Waterproofing sunscreen concentrate comprising a polyvinylpyrrolidone copolymer, organic sunscreen agent, and either titanium dioxide or zinc oxide
Inventor: GRAHAM DAVID E
IPC: A61K8/49
Filed: 1998-11-02
Abstract: A waterproofing sunscreen concentrate in the form of a stable, homogeneous dispersion comprising by weight: i) 30-65% of ultrafine titanium oxide or zinc oxide, or mixtures thereof. ii) 30-70% of an organic sunscreen agent. iii) 0.25-25% of a dispersing aid which is a polyvinylpyrrolidine alkylated with a C4-C36 alpha-olefin. Also described is a sunscreen composition comprising the sunscreen concentrate described above, water and optional adjuvants.